Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Biomarker Changes After Neoadjuvant Therapy: Do They Matter?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Abrial SC, Penault-Llorca F, Delva R, et al. High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer. Breast Cancer Res Treat. 2005;94:255–63.

    Article  Google Scholar 

  2. Kaufmann M, Hortobagyi GN, Goldhirsch A, et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. J Clin Oncol. 2006;24:1940–9.

    Article  Google Scholar 

  3. Xie L, Li X, Wang Q, et al. Effects of core needle biopsy and subsequent neoadjuvant chemotherapy on molecular alterations and outcome in breast cancer. Onco Targets Ther. 2018;11:677–85.

    Article  Google Scholar 

  4. Penault-Llorca F, Radosevic-Robin N. Biomarkers of residual disease after neoadjuvant therapy for breast cancer. Nat Rev Clin Oncol. 2016;13:487–503.

    Article  CAS  Google Scholar 

  5. van de Ven S, Smit VT, Dekker TJ, Nortier JW, Kroep JR. Discordances in ER, PR, and HER2 receptors after neoadjuvant chemotherapy in breast cancer. Cancer Treat Rev. 2011;37:422–30.

    PubMed  Google Scholar 

  6. Mohan SC, Walcott-Sapp S, Lee MK, et al. Alterations in breast cancer biomarkers following neoadjuvant therapy. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-09814-1.

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Cedars Sinai Medical Center, Saul and Joyce Brandman Breast Center at Samuel Oschin Cancer Center, Los Angeles, CA, USA

    Srivarshini Cherukupalli Mohan MD & Alice Chung MD

Authors
  1. Srivarshini Cherukupalli Mohan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alice Chung MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alice Chung MD.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohan, S.C., Chung, A. ASO Author Reflections: Biomarker Changes After Neoadjuvant Therapy: Do They Matter?. Ann Surg Oncol 28, 5918–5919 (2021). https://doi.org/10.1245/s10434-021-09890-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-09890-3

Search

Navigation